Stocks › HAE

HAEMONETICS CORP

HAE·NYSE·United States United States·USD
$120.16
-0.21 (-0.17%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
HAE
HAEMONETICS CORP · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HAES&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of HAE by members of U.S. Congress · 17 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Lois FrankelLois FrankelHouse · D · FL HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
May 25, 2021 May 6, 2021 Filing ↗
Lois FrankelLois FrankelHouse · D · FL HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
May 25, 2021 May 7, 2021 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Feb 9, 2021 Jan 25, 2021 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ HAEHAEMONETICS CORP · Stock Purchase
$1,001 - $15,000
Nov 5, 2020 Oct 16, 2020 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Oct 13, 2020 Sep 15, 2020 Filing ↗
Lois FrankelLois FrankelHouse · D · FL HAEHAEMONETICS CORP · Stock Purchase
$1,001 - $15,000
Aug 24, 2020 Aug 14, 2020 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA HAEHAEMONETICS CORP · Stock Purchase
$1,001 - $15,000
Jun 16, 2020 Jun 1, 2020 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA HAEHAEMONETICS CORP · Stock Purchase
$1,001 - $15,000
Jun 16, 2020 May 19, 2020 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ HAEHAEMONETICS CORP · Stock Purchase
$1,001 - $15,000
Jun 10, 2020 May 28, 2020 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ HAEHAEMONETICS CORP · Stock Purchase
$1,001 - $15,000
Jun 10, 2020 May 15, 2020 Filing ↗
Lois FrankelLois FrankelHouse · D · FL HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Aug 24, 2018 Aug 7, 2018 Filing ↗
Lois FrankelLois FrankelHouse · D · FL HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Jun 22, 2018 Jun 14, 2018 Filing ↗
Lois FrankelLois FrankelHouse · D · FL HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Jun 22, 2018 Jun 7, 2018 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Feb 6, 2014 Jan 16, 2014 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Feb 6, 2014 Jan 21, 2014 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Feb 6, 2014 Jan 24, 2014 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH HAEHAEMONETICS CORP · Stock Sale
$1,001 - $15,000
Jan 27, 2014 Jan 9, 2014 Filing ↗

Whale Activity

Position changes in HAE reported for 2026-09-30 by 393 institutional filers
Increased: 107New: 61Held: 45Decreased: 130Closed: 32No prior filing: 18
  • Increased107
  • New61
  • Held45
  • Decreased130
  • Closed32
  • No prior filing18
FilerSharesValueChange
BlackRock, Inc.6.0M$626.9Mincreased
Neuberger Berman Group LLC3.5M$366.7Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC2.5M$263.4Mdecreased
ARIEL INVESTMENTS, LLC2.2M$228.9Mincreased
VANGUARD CAPITAL MANAGEMENT LLC2.0M$215.4Mdecreased
AQR CAPITAL MANAGEMENT LLC1.8M$189.5Mdecreased
STATE STREET CORP1.8M$189.4Mdecreased
CITADEL ADVISORS LLC1.7M$175.1Mincreased
T. Rowe Price Investment Management, Inc.1.4M$150.3Mincreased
GOLDMAN SACHS GROUP INC1.4M$144.1Mincreased
DIMENSIONAL FUND ADVISORS LP1.3M$134.8Mdecreased
GEODE CAPITAL MANAGEMENT, LLC1.2M$131.2Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by HAE insiders, by quarter · Form 4
-2,000-1,00001,0002,0002025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 1,4002025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: 02026 Q32026 Q4: -8362026 Q4

Recent Insider Transactions

1,860 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Maunsell Farris MaryanneVP, Chief Accounting Officer Sale −836 $120.99 $101K Nov 11, 2026 Form 4 ↗
Madaus Martin DDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
Zane Ellen MDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
Pomeroy ClaireDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
KROLL MARK WDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
Johnson Lloyd EmersonDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
COYLE MICHAEL JDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
Bryant Diane MDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
ABERNATHY ROBERT EDirector Grant / award +2,538 — — Jul 24, 2026 Form 4 ↗
Maunsell Farris MaryanneVP, Chief Accounting Officer Tax withholding −259 $71.28 $18K Jun 5, 2026 Form 4 ↗
Miller Laurie A.SVP, Human Resources Tax withholding −313 $71.28 $22K Jun 5, 2026 Form 4 ↗
Basil Michelle LEVP and General Counsel Grant / award +28.4K — — May 15, 2026 Form 4 ↗
Basil Michelle LEVP and General Counsel Tax withholding −2,913 $56.29 $164K May 15, 2026 Form 4 ↗
Chan FrankEVP, Chief Operating Officer Grant / award +27.5K — — May 15, 2026 Form 4 ↗
Chan FrankEVP, Chief Operating Officer Tax withholding −546 $56.29 $31K May 15, 2026 Form 4 ↗
DArecca JamesEVP, Chief Financial Officer Grant / award +29.3K — — May 15, 2026 Form 4 ↗
DArecca JamesEVP, Chief Financial Officer Tax withholding −2,505 $56.29 $141K May 15, 2026 Form 4 ↗
Maunsell Farris MaryanneVP, Chief Accounting Officer Grant / award +2,220 — — May 15, 2026 Form 4 ↗
Maunsell Farris MaryanneVP, Chief Accounting Officer Tax withholding −197 $56.29 $11K May 15, 2026 Form 4 ↗
Galvin RoyEVP, Chief Commercial Officer Grant / award +27.5K — — May 15, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding HAE · SEC Form N-PORT
FundSharesValue% of fundAs of
Neuberger Genesis Fund
NEUBERGER BERMAN EQUITY FUNDS
1.2M$124.1M1.71%Aug 31, 2026
iShares Core S&P Mid-Cap ETF
iShares Trust
1.6M$119.2M0.10%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.4M$108.1M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
1.2M$92.0M0.11%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.0M$78.1M0.04%Jun 30, 2026
Ariel Fund
Ariel Investment Trust
573.7K$60.4M2.18%Sep 30, 2026
Touchstone Strategic Trust-Touchstone Small Company Fund
Touchstone Strategic Trust
614.8K$46.1M2.68%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
515.3K$44.1M0.13%Jul 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
533.2K$40.0M0.04%Jun 30, 2026
Neuberger Intrinsic Value Fund
NEUBERGER BERMAN EQUITY FUNDS
364.1K$37.5M2.62%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list HAE's shares (CUSIP 405024100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • AQR Capital Management Holdings, LLCSCHEDULE 13G/A · passive (13G) · 2.3M shares5.0%
    Aug 12, 2026 · ↗
  • AQR Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 2.3M shares5.0%
    Aug 12, 2026 · ↗
  • Jeremy Steven KahanSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗
  • Michael Kevin KahanSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗
  • North Peak Capital Ultra Fund, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗
  • North Peak Capital Alpha Fund, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗
  • North Peak Capital Partners II, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗
  • North Peak Capital Partners, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗
  • North Peak Capital GP, LLCSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗
  • North Peak Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    May 13, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming HAEMONETICS CORP as client

No lobbying filings found naming HAEMONETICS CORP as the client.

Government Contracts

Federal awards to haemonetics · USAspending
$480KAwarded · 10 contracts on record
  • Department of Veterans AffairsEXPRESS REPORT NX ORDERS PLACED DURING THE MONTH OF OCTOBER, 2026$24K
    Oct 1, 2026 · ↗
  • Department of Veterans AffairsTEG6 PLATINUM SERVICE$12K
    Sep 16, 2024 · ↗
  • Department of Veterans AffairsTEG ANALYZERS$24K
    Oct 10, 2024 · ↗
  • Department of DefenseVASCADE MVP.$84K
    Jun 2, 2026 · ↗
  • Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF AUGUST, 2026$27K
    Aug 1, 2026 · ↗
  • Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF APRIL, 2026$23K
    Apr 1, 2026 · ↗
  • Department of DefenseHAEMONETICS CORPORATION PROVIDES THE ARTERIAL AND VENOUS CLOSURE SHEATHS REQUIRED FOR CARDIAC ELECTROPHYSIOLOGY PROCEDURES WHICH ENABLE SAME$88K
    Feb 12, 2026 · ↗
  • Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF FEBRUARY 2026$50K
    Feb 1, 2026 · ↗

U.S. Patents

Recent USPTO applications naming HAEMONETICS CORP

No USPTO patent applications found for HAEMONETICS CORP.

Annual Financials

From HAE's 10-K filings · XBRL
Fiscal yearFY2026FY2025FY2024FY2023FY2022
Revenue$1.33B$1.36B$1.31B$1.17B$993.2M
Operating income$156.7M$221.8M$164.9M$156.0M$80.8M
Net income$97.3M$167.7M$117.6M$115.4M$43.4M
Diluted EPS$2.05$3.31$2.29$2.24$0.84
Operating cash flow$293.2M$181.7M$181.8M$273.1M$172.3M
Cash and equivalents$245.4M$306.8M$178.8M$284.5M$259.5M
Total assets$2.40B$2.45B$2.20B$1.93B$1.86B
Shareholders' equity$796.3M$820.8M$960.0M$818.0M$749.4M

As HAEMONETICS CORP tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed May 20, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitDec 3, 2012
  • 2-for-1Stock splitJan 11, 1993

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
    EDGAR ↗
  • 8-K · Items 7.01Reg FD disclosureOct 8, 2026
    EDGAR ↗
  • 8-K · Items 7.01Reg FD disclosureAug 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJul 28, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureJun 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeMay 1, 2026
    EDGAR ↗

About HAEMONETICS CORP

From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersBOSTON, MA
IncorporatedMA